Melissa was in graduate school on the path to become a professor—but was never one to turn down opportunities. As an undergraduate at Penn State, she did a co-op at GSK and found that she thoroughly enjoyed the lab work and environment. Part way through graduate school, GSK contacted her about an opening. Considering her positive experience with the company, she was happy to accept.
Leading a lean team through the early stages of GSK’s drug design and development, Melissa sets out on the challenging search to find inhibitors of epigenetic enzymes and ultimately characterize these interactions. Melissa collaborates with colleagues across GSK’s Research and Development organization daily—enabling studies to be completed that enhance GSK’s existing and future pipeline of cancer treatments.